Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II pilot study of bone marrow mesenchymal stem cells for acute and chronic graft-versus-host disease
2009-011164-11Phase 2Active
- Sponsor
- Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón
- Start
- Mar 2009
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bone marrow-derived mesenchymal stem cells in Acute Graft-Versus-Host Disease (aGvHD) and graft-versus-host disease (GVHD), sponsored by Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón. Primary endpoint: Clinical response rate. Started Mar 2009; status: active.
02
Drugs
bone marrow-derived mesenchymal stem cells
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on 2009-011164-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011164-11.